OSBORN WILLIAM A 4
4 · ABBOTT LABORATORIES · Filed Nov 25, 2020
Insider Transaction Report
Form 4
OSBORN WILLIAM A
Director
Transactions
- Exercise/Conversion
Common shares without par value
2020-11-24$43.64/sh+21,448$935,991→ 79,745 total - Exercise/Conversion
Option (right to buy)
2020-11-24+21,448→ 0 totalExercise: $43.64From: 2017-04-28Exp: 2027-04-27→ Common shares (21,448 underlying)
Footnotes (1)
- [F1]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.